Quick Overview: Jan.12 -- Zhang Wenjie, chief executive officer of Higher productivity, lower hold times, lower costs... Gong Wei discusses the advantages of continuous processing of monoclonal ... Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss China's

Shanghai Henlius Biotech At J - Detailed Overview & Context

Jan.12 -- Zhang Wenjie, chief executive officer of Higher productivity, lower hold times, lower costs... Gong Wei discusses the advantages of continuous processing of monoclonal ... Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss China's Jared Holz, Mizuho, joins 'Fast Money' to talk the uptick in Jared Holz, Mizuho healthcare strategist, joins 'Power Lunch' to discuss the change in sentiment in the healthcare sector, the ... Jared Holz, Mizuho health care equity strategist, joins 'Power Lunch' to discuss investing in

This panel took place at LSI USA '23 Emerging Medtech Summit in Dana Point, CA. This discussion focuses on the perspectives ...

Photo Gallery

Fierce Biotech: Inside Henlius’ Global Growth Strategy
Shanghai Henlius Biotech Working on Covid Treatment Drug
Shanghai Henlius Biotech Inc. 2025 annual report
Shanghai Henlius Biotech Inc. 2025 annual report
Henlius Campus Recruitment Program 2018
GE Bioprocess Days: A discussion with Gong Wei from Henlius Biotech
Dr. Gottlieb on China's biotech strategy: China has become very adept at following U.S. discoveries
Leveragen: Meet Weisheng Chen from our TechNet Partners
Suvannavejh: It has been a remarkable comeback for biotech
If M&A continues at this pace you want to be long Biotech into next year, says Mizuho's Jared Holz
The Street's finally noticing the real assets in biotech, says Mizuho's Jared Holz
Single stock picking is the only way to make money in biotech, says Mizuho's Jared Holz
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored